Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jan 25, 2025. (Total: 235671Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Hyperplasia and CYP3A5[original query]
The androgen receptor CAG repeat length polymorphism associates with prostate volume in Finnish men with benign prostatic hyperplasia.
DNA and cell biology 2008 Feb 27 (2): 109-13.
Renko Outi, Savolainen Eeva-Riitta, Loikkanen Ildikó, Paavonen Timo K, Vaarala Markku
Joint effects of inflammation and androgen metabolism on prostate cancer severity.
International journal of cancer. Journal international du cancer 2008 Sep 123 (6): 1385-9.
Rebbeck Timothy R, Rennert Hanna, Walker Amy H, Panossian Saarene, Tran Teo, Walker Kyle, Spangler Elaine, Patacsil-Coomes Margerie, Sachdeva Rajeev, Wein Alan J, Malkowicz S Bruce, Zeigler-Johnson Charni
ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients.
European journal of clinical pharmacology 2013 Mar 69 (3): 385-93.
García Montserrat, Macías Rosa María, Cubero Juan José, Benítez Julio, Caravaca Francisco, Gervasini Guiller
The influence of UGT2B7, UGT1A8, MDR1, ALDH, ADH, CYP3A4 and CYP3A5 genetic polymorphisms on the pharmacokinetics of silodosin in healthy Chinese volunteers.
Drug metabolism and pharmacokinetics 2012 Dec .
Wang Z, Xiang Q, Cui Y, Zhao X, Zhou Y
Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the ?-adrenergic receptor antagonist.
The aging male : the official journal of the International Society for the Study of the Aging Male 2017 Aug 1-7.
Qian Xiaoqiang, Xu Ding, Liu Hailong, Lin Xiaoling, Yu Yongjiang, Kang Jian, Sheng Xujun, Xu Jianfeng, Zheng Siqun, Xu Danfeng, Qi J
Effects of CYP2D6 and CYP3A5 genetic polymorphisms on steady-state pharmacokinetics and hemodynamic effects of tamsulosin in humans.
European journal of clinical pharmacology 2018 Jun .
Kim Kyoung-Ah, Park In-Bae, Park Ji-You
Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients.
Frontiers in pharmacology 2021 12 12 661443.
Miranda Carla, Galleguillos Macarena, Torres Roberto, Tardón Karla, Cáceres Dante D, Lee Kuen, Redal María A, Varela Nelson M, Quiñones Luis
Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin.
Frontiers in pharmacology 2021 10 12 718281.
Villapalos-García Gonzalo, Zubiaur Pablo, Navares-Gómez Marcos, Saiz-Rodríguez Miriam, Mejía-Abril Gina, Martín-Vílchez Samuel, Román Manuel, Ochoa Dolores, Abad-Santos Francis
[Study of allelic variants of the CYP2D6 and CYP3A genes on the effectiveness and safety of tamsulosin therapy in patients with BPH: results of a pilot study].
Urologiia (Moscow, Russia : 1999) 2023 12 (6): 5-13.
P Abdullaev Sh, N Shatokhin M, N Tuchkova S, P Abdullaev Sh, V Teodorovich O, B Loran O, A Sychev
TOP